Echocardiographic Assessment of the Effect of Impella on Biventricular Function
NCT07534462 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 24
Last updated 2026-04-16
Summary
The objective of this prospective observational study is to evaluate the effects of Impella 5.5 on biventricular function in adult patients with end-stage heart failure requiring temporary mechanical circulatory support. The study will assess changes in left and right ventricular global longitudinal strain and myocardial work, as well as additional echocardiographic and hemodynamic parameters. Measurements will be obtained at baseline prior to Impella implantation, immediately after device initiation, and during postoperative follow-up between 7 and 14 days. This study involves collection of echocardiographic imaging and clinical data, including additional imaging performed for research purposes.
Conditions
- End-stage Heart Failure
Interventions
- DIAGNOSTIC_TEST
-
Echocardiographic Assessment
Echocardiographic imaging will be performed at baseline prior to Impella implantation, immediately after device initiation, and during postoperative follow-up between Day 7 and Day 14 to assess biventricular function.
Sponsors & Collaborators
- collaborator INDUSTRY
-
University of Rochester
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-15
- Primary Completion
- 2027-04-15
- Completion
- 2027-04-15
- FDA Device
- Yes
More Related Trials
-
Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
NCT06517186 ·Status: RECRUITING
-
Renal Denervation in Heart Failure With Preserved Ejection Fraction
NCT01840059 ·Status: COMPLETED ·Phase: PHASE2
-
The Use of Advanced Imaging in HFpEF
NCT06905405 ·Status: RECRUITING
-
Effect of NT-proBNP Guided Treatment of Chronic Heart Failure
NCT00149422 ·Status: COMPLETED ·Phase: NA
-
Role of Sacubitril/Valsartan in the Improvement of Heart Failure With Reduced Ejection Fraction
NCT04397302 ·Status: COMPLETED
-
Treatment of Non-ischemic Cardiomyopathies by Intravenous Extracellular Vesicles of Cardiovascular Progenitor Cells
NCT05774509 ·Status: RECRUITING ·Phase: PHASE1
-
Circulating NEP and NEP Inhibition Study in Heart Failure With Preserved Ejection Fraction
NCT03506412 ·Status: COMPLETED ·Phase: PHASE4
-
Renal Denervation in Patients With Heart Failure With Normal LV Ejection Fraction
NCT02115230 ·Status: UNKNOWN ·Phase: NA
-
Study Dosed With (123I-mIBG) for Identifying Subjects With Heart Failure Who Will Experience an Adverse Cardiac Event
NCT00785044 ·Status: COMPLETED
-
Incidence and Echocardiographic Predictors of HFpEF in High-Risk Population Afferent to Italian Echo-labs Network
NCT05753553 ·Status: UNKNOWN
-
Empagliflozin in Heart Failure Patients With Reduced Ejection Fraction
NCT03198585 ·Status: COMPLETED ·Phase: PHASE2
-
Developing Imaging And plasMa biOmarkers iN Describing Heart Failure With Preserved Ejection Fraction (DIAMONDHFpEF)
NCT03050593 ·Status: COMPLETED
-
Association Between Coronary and Peripheral Vascular Injury in Heart Failure Patients With Preserved Ejection Fraction.
NCT05884346 ·Status: UNKNOWN ·Phase: NA
-
Guiding Evidence Based Therapy Using Biomarker Intensified Treatment
NCT01685840 ·Status: TERMINATED ·Phase: NA
-
Reverse Remodeling Effects of CDR132L in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Cardiac Hypertrophy
NCT05953831 ·Status: WITHDRAWN ·Phase: PHASE2
-
Reduced Contractile Reserve: a Therapeutic Target in Heart Failure With Preserved Ejection Fraction(HFpEF)
NCT01354613 ·Status: COMPLETED ·Phase: NA
-
Comparison of Diuretic-based With Non-diuretic Based Hypertension Therapy Using Echocardiographic Measures
NCT00229242 ·Status: COMPLETED ·Phase: NA
-
Meta-Iodobenzylguanidine (123I-mIBG) Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease
NCT00126438 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Dapagliflozin on VT in Patients With Heart Failure.
NCT05550441 ·Status: UNKNOWN ·Phase: PHASE4
-
SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure
NCT06955260 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Study for the Treatment of Heart Failure With Preserved Ejection Fraction Associated With High Blood Pressure Using Right Atrial Pacing Controlled by the PressurePaceTM System
NCT06036186 ·Status: COMPLETED ·Phase: NA
-
Hemodynamic Effects of Rolofylline in the Treatment of Patients With Heart Failure (7418-503)
NCT00729222 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
NCT06979362 ·Status: RECRUITING ·Phase: PHASE2
-
EMPA Acute Heart Failure
NCT03554200 ·Status: TERMINATED ·Phase: PHASE2
-
Renal Denervation to Treat Heart Failure With Preserved Ejection Fraction
NCT05030987 ·Status: RECRUITING ·Phase: NA